Oct 2026· International Journal of Pharmaceutics: X· Vol 12· 0 citations· 193 references
Medicine
TL;DR
This review provides a critical overview of NMOF synthesis and design strategies for anticancer applications and discusses MOF-based single imaging and therapy, imaging-guided drug delivery, and drug-free cancer theranostics.
Abstract
Diagnosis and treatment are typically separate procedures, and their integration into theranostics holds great promise for precision medicine. Metal-organic frameworks (MOFs), assembled from metal nodes and organic ligands, are versatile platforms for multifunctional theranostics due to their integratable components and porous structure for loading active species. However, fabricating nanoscale MOFs (NMOFs) is essential for biomedical applications, as nanosize is required to cross physiological barriers for effective delivery. This review provides a critical overview of NMOF synthesis and design strategies for anticancer applications. Synthesis methods are organized from a mechanistic perspective, including self-limiting growth, seed-growing, template-assisted, kinetic-control, and competitive coordination-induced strategies, and are compared in terms of scalability, reproducibility, and pharmaceutical suitability. We then discuss MOF-based single imaging and therapy, imaging-guided drug delivery, and drug-free cancer theranostics. The combination of MOFs with nanozymes, either as carriers or/and intrinsic nanozymes, is also addressed. Finally, the toxicity profile, challenges, and future prospects for translational applications of NMOFs are outlined. In conclusion, the clinical translation of MOF-based theranostics remains in its early stages, and substantially greater efforts are required before high-performance NMOFs can reach clinical application.
Metal-organic frameworks (MOFs) are tuneable porous platforms for cancer drug delivery, as their metal nodes, organic linkers, pore architecture, and surface chemistry can be engineered to control cargo loading, targeting, degradation, and stimulus-responsive release. This review critically discusses the composition-st...
Lama Ahmed Alahmary, Farah Ayman Sukkarieh, U. T. Ferdous et al.· European journal of medicina...· 0 citations
Metal-organic frameworks (MOFs) have emerged as a versatile class of porous nanomaterials for cancer therapy owing to their programmable compositions, ordered architectures, and multifunctional properties. Among them, meso-tetra(4-carboxyphenyl)porphyrin (TCPP)-based MOFs have attracted particular attention because the...
Huan Zhang, Peng-Yu Li, Yu-Jie Zhang et al.· Smart Materials and Devices· 0 citations
Metal-organic frameworks (MOFs) offer high surface area, tunable porosity, and modular chemistry that support biomedical applications. Pristine metal-organic frameworks face aqueous instability and safety concerns; thus, incorporation with biopolymers provides a viable strategy to enhance structural integrity. Existing...
Kien G. Nguyen, L. M. Nguyen, D. Nguyen et al.· International Journal of Bio...· 0 citations
Metal–organic frameworks (MOFs) have emerged as versatile carriers for biomedical applications because of their tunable porosity, high surface area, and structural robustness. Their biocompatibility depends on carefully selecting nontoxic metals such as Fe, Zn, or Mg; safe organic ligands, including carboxylates, imida...
Danna P. Vázquez-Poxtan, Lidia E. Chiñas-Rojas, E. Flores-Andrade et al.· ChemMedChem· 0 citations
Biomedical micro/nanosystems are rapidly advancing toward integration of therapeutic and diagnostic nanoscale agents into unified platforms. Engineers still struggle to precisely control multiple functions in biocompatible designs. Copper ferrite (CuFe2O4) nanoparticles represent a compelling material solution, combini...
Inorganic chemistry continues to supply a distinctive and expanding toolkit for biomedical application, exploiting coordination geometry, redox activity, and nanoscale physical properties that are largely inaccessible to purely organic small molecules. This review surveys four convergent domains of contemporary biomedi...
S. Jain, Yogesh Sharma Sharma, Jyoti Rajput Rajput et al.· Indian Journal of Pharmaceut...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.